In this week's video, Dr. Brian G.M. Durie discusses ongoing clinical trials that use such drugs as venetoclax, selinexor, Farydak (panobinostat), and subcutaneous daratumumab.

Yes, there are new drugs available to treat myeloma with positive results.

Have a question? Submit it to

IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to!

For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at

Previous Post
In the News: New Drug Updates and Notes on the Environment
Next Post
Why is 17p deletion (17p-) considered to be a poor prognostic factor for myeloma patients?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.